Veterinary healthcare in Japan has had a significant boost in revenues due to a number of factors. Prominent among them are the escalating occurrence of zoonotic diseases, growing consumer focus on animal health and food safety, and increasing pet ownership. Going forward, the key factor for the growth of Japan’s animal health market will be the need to increase production of farm animal products (eggs, milk, beef and other dairy products).
In Japan, the market for vaccines in 2014 is estimated to be US$1.04 billion and is expected to grow at a CAGR of 8.31 % between 2011 and 2019, to reach US$1.57 billion by 2019. The market for paraciticides in the region is currently at US$ 168 million – a significant increase from 2013. Increasing focus on food safety and animal health will drive the market for medicinal feed additives to grow at a healthy CAGR of 6.65%.
Key companies operating in the Veterinary healthcare market in Japan are Zoetis, Merck, Merial, Bayer and Novartis.Growth strategies adopted by these players in the past have differed significantly. While a few like Zoestis and Bayer animal healthcare have focused on horizontal growth by expanding their presence in emerging markets, others like Elanco and Novartis animal healthcare have been content to operate within their established boundaries, going in for vertical growth by product innovation instead.
This report provides a comprehensive analysis of Japan’s veterinary healthcare market based on:
1) Type of products: vaccines, anti-infective, paraciticides, medicinal feed additives and other pharmaceuticals
2) Type of animal:
i) Farm animals: swine, poultry, cattle, sheep and fish
ii) Companion animals:dogs, cats and horses
Companies analyzed in the report include Zoetis Animal Healthcare, Merck Ltd., Merial (The Animal health division of Sanofi), Elanco Animal Health, Bayer Animal Health, Novartis Animal Health, Virbac Animal Health and Boehringer Ingelheim.
1.2. Definition of the market
2. KEY FINDINGS OF THE STUDY
3.Japan Veterinary Healthcare Market – Overview
4. GLOBAL MARKET ANALYSIS
4.1. Livestock Industry Trend
4.2 Farm animals Health Trend
4.3 Companion animals health trend
4.4. Threshold matters of the Industry
4.5. Factors Affecting the Global Market
4.6. Porters Analysis
4.6.1. Bargaining power of Buyers
4.6.2. Bargaining power of Suppliers
4.6.3. Degree of Competition
4.6.4. Threat of new entrants
4.6.5. Threat of Substitutes
4.7. Global Regulatory Environment-Impact Analysis
4.8. Value Chain Analysis
5.Japan’s Share in the Asia-Pacific Veterinary health care market.
6. Japan’s Animal Veterinary care market- Market Segmentation by products
6.4 Medicinal Feed Additives
6.5 Other Phamaceuticals
7. Japan’s Veterinary health care market- Market Segmentation by Animals
7.1 Farm animal health market
7.1.1 Poultry health market
7.1.2 Swine health market
7.1.3 Fish health market
7.1.4 Cattle health market
7.1.5 Sheep health market
7.2 Companion animal health market
7.2.1 Dogs and Cats Market
7.2.2 Horse health market
8. The future of the industry-Expert View
9. Key players’ profile – Global
9.1 Zoetis Animal Healthcare
9.2 Merck Ltd.
9.3 Merial ( Animal Health division of Sanofi)
9.4 Elanco Animal Health
9.5 Bayer Animal Health
9.6 Novartis Animal Health